BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired Fidelis Research, an 85-site clinical biospecimen collection network in Southeastern Europe with headquarters in Sofia, Bulgaria. Fidelis Research also possesses cell isolation capabilities and provides custom contract research services for pharmaceutical companies and clinical research organizations (CROs). “This transaction further increases the scale and depth of BioIVT’s glob...